C. Huerta-Álvarez

发表

The Risk of SARS-CoV-2 Infection in Pregnant Women: An Observational Cohort Study Using the BIFAP Database

L. Cea-Soriano, Mercedes Mota, C. Huerta-Álvarez, 2022, Healthcare.

Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

L. G. García Rodríguez, Luis A. García Rodríguez, Consuelo Huerta-Alvarez, 2001, Epidemiology.

Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark

A. Pottegård, T. Duarte-Salles, A. Llorente-García, 2022, Frontiers in Pharmacology.

RETRACTED ARTICLE: The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 6 Years After Approval

E. Martín-Merino, A. Llorente-García, D. Montero Corominas, 2019, Pharmaceutical Medicine.

Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.

L. G. García Rodríguez, L A García Rodríguez, C Huerta-Alvarez, 2000, Epidemiology.

Thromboembolic Events in a Socio-Economically Disadvantaged Population with COVID-19 Admitted to a Medicalized Hotel in Madrid

C. Huerta-Alvarez, M. Quintana-Díaz, K. L. Ramírez-Cervantes, 2022, International journal of environmental research and public health.

The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval

E. Martín-Merino, A. Llorente-García, D. Montero Corominas, 2019, Pharmaceutical Medicine.

Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.

R. Gini, M. Sturkenboom, Lara Tramontan, 2019, Vaccine.

ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.

M. Sturkenboom, Lara Tramontan, K. Bollaerts, 2019, Vaccine.

Secular trends of use of anti-osteoporotic treatments in Spain: A population-based cohort study including over 1.5million people and more than 12years of follow-up.

D. Prieto-Alhambra, A. Álvarez-Gutiérrez, D. Montero-Corominas, 2017, Bone.

Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis

D. Prieto-Alhambra, D. Montero-Corominas, C. Huerta-Alvarez, 2017, Archives of Osteoporosis.

Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication

D. González-Bermejo, Pilar Rayón-Iglesias, Alfonso Rodríguez-Pascual, 2020, Pharmacoepidemiology and drug safety.

ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.

S. de Lusignan, R. Gini, M. Sturkenboom, 2020, Vaccine.

Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.

S. de Lusignan, M. Sturkenboom, Lara Tramontan, 2020, Vaccine.

ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.

S. de Lusignan, M. Sturkenboom, M. D. de Ridder, 2020, Vaccine.

ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.

S. de Lusignan, M. Sturkenboom, Lara Tramontan, 2019, Vaccine.

ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.

M. Sturkenboom, Lara Tramontan, K. Bollaerts, 2019, Vaccine.